An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

single dose of 7.5 mg PF-06372865 alone (period 1) or co-administered with itraconazole (period 2)

Interacting drug which will be given 200 mg QD for 8 days in period 2